← Open Payments lookup

AMY JANOFSKI: Open Payments

NPI 1427654516 · SHEPHERD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$609 in 24 payments from 12 companies in 2025. Trend: 2023 $65 · 2024 $426 · 2025 $609

Food & beverage: $582Education: $28
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$147
Takeda Pharmaceuticals U.S.A., Inc.4$101
Vanda Pharmaceuticals Inc.3$68
Antares Pharma, Inc.4$68
Novo Nordisk Inc2$45
ABBVIE INC.2$37
GlaxoSmithKline, LLC.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
Lilly USA, LLC1$26
Astellas Pharma US Inc1$23

Products named: AIRSUPRA, EOHILIA, FANAPT, XYOSTED, VRAYLAR, TRELEGY ELLIPTA, CAPLYTA, ZEPBOUND.

Industry payments across MI — which companies pay providers there.